$2.31T
Total marketcap
$127.29B
Total volume
BTC 49.77%     ETH 15.76%
Dominance

Becton, Dickinson and Company BOX.DE Stock

223 EUR {{ price }} -1.108648% {{change_pct}}%
COUNTRY
Germany
Exchange
XETRA
Market Cap
64.43B EUR
LOW - HIGH [24H]
223 - 223 EUR
VOLUME [24H]
39 EUR
{{ volume }}
P/E Ratio
54.92
Earnings per share
4.06 EUR

Becton, Dickinson and Company Price Chart

Becton, Dickinson and Company BOX.DE Financial and Trading Overview

Becton, Dickinson and Company stock price 223 EUR
Previous Close 233.5 EUR
Open 235.5 EUR
Bid 233 EUR x N/A
Ask 235 EUR x N/A
Day's Range 234.5 - 235.5 EUR
52 Week Range 213.2 - 265.45 EUR
Volume 30 EUR
Avg. Volume 69 EUR
Market Cap 66.6B EUR
Beta (5Y Monthly) 0.572535
PE Ratio (TTM) 45.27027
EPS (TTM) 4.06 EUR
Forward Dividend & Yield 3.38 (1.45%)
Ex-Dividend Date June 8, 2023
1y Target Est N/A

BOX.DE Valuation Measures

Enterprise Value 83.69B EUR
Trailing P/E 45.27027
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm) 3.540939
Price/Book (mrq) 2.5928218
Enterprise Value/Revenue 4.45
Enterprise Value/EBITDA 17.418

Trading Information

Becton, Dickinson and Company Stock Price History

Beta (5Y Monthly) 0.572535
52-Week Change 7.34%
S&P500 52-Week Change 20.43%
52 Week High 265.45 EUR
52 Week Low 213.2 EUR
50-Day Moving Average 231.57 EUR
200-Day Moving Average 232.68 EUR

BOX.DE Share Statistics

Avg. Volume (3 month) 69 EUR
Avg. Daily Volume (10-Days) 56 EUR
Shares Outstanding 284.02M
Float 283.39M
Short Ratio N/A
% Held by Insiders 0.35%
% Held by Institutions 89.74%
Shares Short N/A
Short % of Float N/A
Short % of Shares Outstanding N/A

Dividends & Splits

Trailing Annual Dividend Rate 3.56
Trailing Annual Dividend Yield 1.52%
5 Year Average Dividend Yield N/A
Payout Ratio 0.65440005
Last Split Factor

Financial Highlights

Fiscal Year

Fiscal Year Ends September 30, 2022
Most Recent Quarter (mrq) March 31, 2023
Next Fiscal Year End September 30, 2023

Profitability

Profit Margin 8.59%
Operating Margin (ttm) 13.50%
Gross Margin 45.70%
EBITDA Margin 25.54%

Management Effectiveness

Return on Assets (ttm) 2.90%
Return on Equity (ttm) 6.55%

Income Statement

Revenue (ttm) 18.81B EUR
Revenue Per Share (ttm) 66.1 EUR
Quarterly Revenue Growth (yoy) 1.50%
Gross Profit (ttm) 8.61B EUR
EBITDA 4.81B EUR
Net Income Avi to Common (ttm) 1.56B EUR
Diluted EPS (ttm) 5.18
Quarterly Earnings Growth (yoy) 1.30%

Balance Sheet

Total Cash (mrq) 1.99B EUR
Total Cash Per Share (mrq) 7 EUR
Total Debt (mrq) 18.22B EUR
Total Debt/Equity (mrq) 70.94 EUR
Current Ratio (mrq) 1.313
Book Value Per Share (mrq) 90.442

Cash Flow Statement

Operating Cash Flow (ttm) 2.1B EUR
Levered Free Cash Flow (ttm) 1.76B EUR

Profile of Becton, Dickinson and Company

Country Germany
State NJ
City Franklin Lakes
Address 1 Becton Drive
ZIP 07417-1880
Phone 201 847 6800
Website https://www.bd.com
Industry Medical Instruments & Supplies
Sector(s) Healthcare
Full Time Employees 77000

Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment provides peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular care and preparation products, needle-free IV connectors and extensions sets, closed-system drug transfer devices, hazardous drug detections, hypodermic syringes and needles, anesthesia needles and trays, enteral syringes, and sharps disposal systems; IV medication and infusion therapy delivery systems, medication compounding workflow systems, automated medication dispensing and supply management systems, and medication inventory optimization and tracking systems; syringes, pen needles, and other products for diabetes; and prefillable drug delivery systems. Its BD Life Sciences segment offers specimen and blood collection products; automated blood and tuberculosis culturing, molecular testing, microorganism identification and drug susceptibility, and liquid-based cytology systems, as well as rapid diagnostic assays, microbiology laboratory automation products, and plated media products; and fluorescence-activated cell sorters and analyzers, antibodies and kits, reagent systems, and solutions for single-cell gene expression analysis, as well as clinical oncology, immunological, and transplantation diagnostic/monitoring reagents and analyzers. The company's BD Interventional segment provides hernia and soft tissue repair, biological and bioresorbable grafts, biosurgery, and other surgical products; surgical infection prevention, surgical and laparoscopic instrumentation products; peripheral intervention products; and urology and critical care products. The company was founded in 1897 and is based in Franklin Lakes, New Jersey.

Q&A For Becton, Dickinson and Company Stock

What is a current BOX.DE stock price?

Becton, Dickinson and Company BOX.DE stock price today per share is 223 EUR.

How to purchase Becton, Dickinson and Company stock?

You can buy BOX.DE shares on the XETRA exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for Becton, Dickinson and Company?

The stock symbol or ticker of Becton, Dickinson and Company is BOX.DE.

Which industry does the Becton, Dickinson and Company company belong to?

The Becton, Dickinson and Company industry is Medical Instruments & Supplies.

How many shares does Becton, Dickinson and Company have in circulation?

The max supply of Becton, Dickinson and Company shares is 288.9M.

What is Becton, Dickinson and Company Price to Earnings Ratio (PE Ratio)?

Becton, Dickinson and Company PE Ratio is 54.92611000 now.

What was Becton, Dickinson and Company earnings per share over the trailing 12 months (TTM)?

Becton, Dickinson and Company EPS is 4.06 EUR over the trailing 12 months.

Which sector does the Becton, Dickinson and Company company belong to?

The Becton, Dickinson and Company sector is Healthcare.